German Perdomo

Valladolid, CL 47003, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Insulin Clearance Along the Liver-Kidney Axis: Implications for Insulin Action.

Insulin Clearance Along the Liver-Kidney Axis: Implications for Insulin Action.

Journal: Metabolites

Published: April 21, 2026

Chronic attenuation of brain leptin signalling is associated with early metabolic dysfunction in lean rats.

Chronic attenuation of brain leptin signalling is associated with early metabolic dysfunction in lean rats.

Journal: The Journal of physiology

Published: January 14, 2026

Glucagon secretion by pancreatic alpha-cells requires an intact tubulin-cytoskeleton-primary cilium axis.

Glucagon secretion by pancreatic alpha-cells requires an intact tubulin-cytoskeleton-primary cilium axis.

Journal: Molecular medicine (Cambridge, Mass.)

Published: January 05, 2026

Decreased expression of insulin-degrading enzyme increases gluconeogenesis and glucose production in cultured hepatocytes administered with glucagon.

Decreased expression of insulin-degrading enzyme increases gluconeogenesis and glucose production in cultured hepatocytes administered with glucagon.

Journal: Scientific reports

Published: March 17, 2025

β2-Chimaerin, a GTPase-Activating Protein for Rac1, Is a Novel Regulator of Hepatic Insulin Signaling and Glucose Metabolism.

β2-Chimaerin, a GTPase-Activating Protein for Rac1, Is a Novel Regulator of Hepatic Insulin Signaling and Glucose Metabolism.

Journal: Molecules (Basel, Switzerland)

Published: October 10, 2024

Hyperglucagonemia and glucagon hypersecretion in early type 2 diabetes result from multifaceted dysregulation of pancreatic mouse α-cells.

Hyperglucagonemia and glucagon hypersecretion in early type 2 diabetes result from multifaceted dysregulation of pancreatic mouse α-cells.

Journal: Pflugers Archiv : European journal of physiology

Published: June 18, 2024

Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.

Correction to: Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.

Journal: Diabetologia

Published: November 15, 2023

Pharmacological activation of insulin-degrading enzyme improves insulin secretion and glucose tolerance in diet-induced obese mice.

Pharmacological activation of insulin-degrading enzyme improves insulin secretion and glucose tolerance in diet-induced obese mice.

Journal: Diabetes, obesity & metabolism

Published: March 05, 2023

Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge.

Altered Surface Expression of Insulin-Degrading Enzyme on Monocytes and Lymphocytes from COVID-19 Patients Both at Diagnosis and after Hospital Discharge.

Journal: International journal of molecular sciences

Published: July 17, 2022

The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia.

The Relationship between Angiogenic Factors and Energy Metabolism in Preeclampsia.

Journal: Nutrients

Published: April 21, 2022

Primary Cilia in Pancreatic β- and α-Cells: Time to Revisit the Role of Insulin-Degrading Enzyme.

Primary Cilia in Pancreatic β- and α-Cells: Time to Revisit the Role of Insulin-Degrading Enzyme.

Journal: Frontiers in endocrinology

Published: April 18, 2022

Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.

Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.

Journal: Diabetologia

Published: January 29, 2022

Showing 1-12 of 44

Last Updated: 09/26/2026